<DOC>
	<DOCNO>NCT01553279</DOCNO>
	<brief_summary>Primary objective • To evaluate concomitant administration PR5I two type MCC vaccine ( MCC-TT MCC-CRM ) Secondary objectives Part I - To describe immunogenicity PR5I PR5I give 2 month age concomitantly MCC vaccine 3 4 month age - To describe immunogenicity MCC vaccine MCC vaccine give concomitantly PR5I 3 4 month age ( post-dose 1 post-dose 2 ) - To describe safety PR5I give concomitantly PCV-13 MCC vaccine Part II • To describe immunogenicity safety Hib-MCC give 12 month age subject receive PR5I 2 , 3 4 month age</brief_summary>
	<brief_title>Immunogenicity Safety V419 Given 2 , 3 4 Months Age With Meningococcal Serogroup C Conjugate Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infant 46 74 day age ( inclusive ) Parent ( ) /legal representative able comply study procedure Subject participate study investigational compound device since birth History congenital acquire immunodeficiency History leukemia , lymphoma , malignant melanoma myeloproliferative disorder Chronic illness could interfere study conduct completion Hypersensitivity vaccines component history lifethreatening reaction vaccine contain substance study vaccine contraindication study vaccine History mother history HBsAg seropositivity Coagulation disorder contraindicate intramuscular injection History vaccination hepatitis B , Haemophilus influenzae type b conjugate , diphtheria , tetanus , pertussis ( acellular wholecell ) , poliovirus , pneumococcal conjugate polysaccharide , meningococcal serogroup C conjugate , measles , mumps , rubella contain vaccine ( ) History hepatitis B , Haemophilus influenzae type b , diphtheria , tetanus , pertussis , poliomyelitis , invasive pneumococcal , meningococcal serogroup C , measles , mumps rubella infection Receipt immune globulin , blood bloodderived product , immunosuppressive agent systemic corticosteroid since birth Vaccination inactivate ( except influenza vaccine ) conjugate live vaccine last 30 day vaccination inactivate influenza vaccine last 14 day Antipyretic , analgesic nonsteroidal antiinflammatory medication last 48 hour Febrile illness body temperature ≥38.0°C last 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>46 Days</minimum_age>
	<maximum_age>74 Days</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>